Autism Spectrum Disorders Clinical Trial
Official title:
A Randomized, Cross-Over Study of the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD and Sleep Disturbances
The purpose of the present study is to evaluate the tolerability and efficacy of the Sound To
Sleep System™ in improving the sleep quality of children with Autism Spectrum Disorder (ASD).
The Sound To Sleep System™ is a mattress foundation designed to improve sleep quality in
individuals with ASD and sleep disturbance by providing mattress vibrations that accompany
and sync with auditory stimulation. For the present study, the primary objectives are as
follows:
* Study Aim 1 - To determine whether the use of the Sound To Sleep System™ in ASD-affected
children with sleep disturbances is well tolerated as defined by group drop-out proportion
due to issues with the mattress technology.
The study will also explore the following objectives:
- Study Aim 2 - To determine the efficacy of the Sound To Sleep System™ in improving sleep
quality as measured by parent reported sleep quality in ASD-affected children with sleep
disturbances. (Please note Study Aim 2 was changed from clinician-rated to parent-rated
because we were not able to collect clinician-rated sleep quality information).
- Study Aim 3 - To determine the tolerability of the Sound To Sleep System™ as defined by
study drop-out due to any reason and caregiver ratings of ease of mattress technology
use.
- Study Aim 4 - To determine whether use of the mattress technology improves functioning
as defined by secondary outcome measures.
The present study aims to evaluate the tolerability and efficacy of a new mattress technology
in improving the sleep quality of children with Autism Spectrum Disorder (ASD). Clinical and
population studies indicate that children with ASD exhibit elevated rates of sleep
disturbance compared to their typically-developing peers and that 50% to 80% of children with
ASD have sleep problems. Sleep disturbance can include bedtime resistance, sleep onset
latency, nighttime awakenings, decreased total sleep time, early morning awakenings, and
other measures of sleep quality. Sleep problems in children with ASD are associated with
greater externalizing and internalizing behavior problems during the waking day, poorer
adaptive functioning, and can cause significant parental stress. Previous studies have
examined the effectiveness of behavioral treatments, environmental modifications, melatonin,
and psychopharmacologic treatments in decreasing the rates of sleep disturbance. However,
none of these approaches have identified treatments that are effective for all ASD-affected
children with sleep difficulties. Given the high prevalence of sleep disturbance in this
population, there is a great need to identify additional treatments that may improve sleep in
children with ASD.
The purpose of the present study is to evaluate the tolerability and efficacy of the Sound To
Sleep System™ using a single blind (actigraphy scoring blinded), cross-over design. The Sound
To Sleep System™ is a mattress foundation designed to improve sleep quality in individuals
with ASD and sleep disturbance by providing mattress vibrations that accompany and sync with
auditory stimulation. For the present study, the primary objectives are as follows:
Study Aim 1- To determine whether the use of the Sound To Sleep System™ in ASD-affected
children with sleep disturbances is well tolerated as defined by group drop-out proportion
due to issues with the mattress technology.
The study will also explore the following objectives:
Study Aim 2- To determine the efficacy of the Sound To Sleep System™ in improving
parent-reported sleep quality in ASD-affected children with sleep disturbances.
Study Aim 3- To determine the tolerability of the Sound To Sleep System™ as defined by study
drop-out due to any reason and caregiver ratings of ease of mattress technology use.
Study Aim 4- To determine whether use of the mattress technology improves functioning as
defined by secondary outcome measures.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02625116 -
ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders
|
||
Not yet recruiting |
NCT06381856 -
Improving Participation of Autistic Children and Adolescents in the Habilitation Process
|
||
Recruiting |
NCT02280746 -
Gluten for Autism Spectrum Disorders
|
N/A | |
Completed |
NCT01945957 -
Brain Imaging of Intranasal Oxytocin Treatment in Autism
|
Phase 1 | |
Completed |
NCT01661855 -
A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD
|
Phase 2 | |
Completed |
NCT01694667 -
Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
|
Phase 2 | |
Completed |
NCT01780090 -
Handheld Technology for Speech Development in Students With Autism
|
N/A | |
Completed |
NCT01592747 -
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
|
Phase 2 | |
Completed |
NCT01691066 -
Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder
|
N/A | |
Active, not recruiting |
NCT01417026 -
Intranasal Oxytocin and Learning in Autism
|
Phase 2 | |
Enrolling by invitation |
NCT01364818 -
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
|
N/A | |
Completed |
NCT01695200 -
Omega-3 Fatty Acids in Autism Spectrum Disorders
|
Phase 4 | |
Completed |
NCT02300597 -
Internet-based Support for Young People With ADHD and Autism - a Controlled Study
|
N/A | |
Not yet recruiting |
NCT00695812 -
The Development of Younger Siblings of Children With Autism Now at 10 Years of Age
|
N/A | |
Completed |
NCT01675414 -
Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD)
|
N/A | |
Recruiting |
NCT05910502 -
Project AFECT (Autism Family Empowerment Coaching and Training Program)
|
N/A | |
Completed |
NCT02081027 -
Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
|
Early Phase 1 | |
Completed |
NCT02797379 -
The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders
|
N/A | |
Terminated |
NCT01730079 -
Near Infrared Spectroscopy in Children With Autism and ADHD
|
||
Completed |
NCT01603225 -
Transcranial Direct Current Stimulation and Autism
|